How should cough‑induced chest wall pain be managed?

Management of Cough-Induced Chest Wall Pain

For cough-induced chest wall pain, start with simple analgesics (NSAIDs or acetaminophen) for pain control while simultaneously treating the underlying cough with a stepwise pharmacologic approach beginning with over-the-counter demulcents, escalating to opioid antitussives if needed.

Initial Assessment

Look specifically for:

• Red flags: Hemoptysis, severe dyspnea, fever with systemic illness, history of malignancy, or suspicion of rib fracture
• Duration of cough (acute <3 weeks, subacute 3-8 weeks, chronic >8 weeks) 1
• Characteristics suggesting serious pathology: progressive breathlessness, weight loss, night sweats
• Medication history: ACE inhibitors, sitagliptin 1
• Smoking status and occupational/environmental exposures 2, 1

Diagnostic Approach

Imaging Considerations

• Chest radiography is reasonable if you suspect rib fracture, pneumonia, or pneumothorax, though it detects fractures in only ~5% of nontraumatic chest pain cases 3
• CT chest should be reserved for patients with clinical risk factors (trauma history, infection, malignancy concern) or when pulmonary disease evaluation is needed 3
• For isolated chest wall pain without red flags, imaging may not change management initially 3

Cough Etiology by Duration

The underlying cause drives treatment strategy 2, 1:

Acute cough (<3 weeks): Usually viral upper respiratory infection, acute bronchitis, or environmental exposure

Subacute cough (3-8 weeks): Most commonly post-infectious; consider upper airway cough syndrome (UACS), transient bronchial hyperresponsiveness, asthma, or pertussis 1

Chronic cough (>8 weeks): UACS, asthma, GERD, non-asthmatic eosinophilic bronchitis, or combinations 1

Treatment Algorithm

Step 1: Pain Management

• NSAIDs or acetaminophen for chest wall pain relief
• Address any rib fractures conservatively with analgesics

Step 2: Cough Suppression (Stepwise Escalation)

First-Line: Demulcents/OTC Preparations

Start with simple, low-cost options 4:

• Simple linctus (syrup): 5 mL three to four times daily
• Glycerol-based cough syrups (various OTC brands)
• Dextromethorphan: 10-15 mg three to four times daily (maximum 120 mg/day) 4, 5
• Honey and lemon as home remedy 5

These have low side-effect profiles and some evidence of benefit, though they may be less effective for severe cough 4.

Second-Line: Opioid Antitussives

If demulcents fail after adequate trial, escalate to opioids 4:

Preferred opioids (in order):

1. Pholcodine: 10 mL four times daily (where available)
2. Hydrocodone: 5 mg twice daily (where available)
3. Dihydrocodeine: 10 mg three times daily
4. Morphine: 5 mg single-dose trial; if effective, use 5-10 mg slow-release twice daily 4

Avoid codeine as first-choice opioid despite being most studied—it has a greater side-effect profile compared to alternatives 4.

Third-Line: Peripherally-Acting Antitussives

For opioid-resistant cough 4:

• Levodropropizine: 75 mg three times daily
• Moguisteine: 100-200 mg three times daily
• Levocloperastine: 20 mg three times daily
• Sodium cromoglycate (inhaled): 10 mg four times daily

Fourth-Line: Local Anesthetics

For intractable cough unresponsive to all above 4:

• Nebulized lidocaine: 5 mL of 0.2% three times daily
• Nebulized bupivacaine: 5 mL of 0.25% three times daily
• Benzonatate: 100-200 mg four times daily

Critical caveat: Local anesthetics increase aspiration risk—assess swallowing function before use and avoid food/drink for at least 1 hour after administration 4.

Step 3: Treat Underlying Cause

Based on cough duration and clinical features 2, 1:

For post-infectious/subacute cough:

• Trial of first-generation antihistamine/decongestant for UACS
• Consider inhaled corticosteroids if bronchial hyperresponsiveness suspected

For chronic cough:

• UACS: First-generation antihistamine/decongestant 2
• Asthma/cough-variant asthma: Inhaled corticosteroids first-line, escalate dose or add leukotriene inhibitor if incomplete response 6
• GERD: Note that acid suppression alone is no longer recommended 1
• Non-asthmatic eosinophilic bronchitis: Inhaled corticosteroids 6

Follow-Up and Monitoring

• Use a validated cough severity or quality-of-life tool to objectively assess response 1
• Follow up within 4-6 weeks after initial evaluation 1
• If cough persists despite appropriate sequential therapy, consider referral to a specialized cough clinic 2, 1

Common Pitfalls

1. Inadequate treatment duration: Give each therapeutic trial sufficient time (typically 2-4 weeks) before declaring failure
2. Missing multiple causes: Cough often has >1 etiology—use sequential AND additive therapy 2
3. Overlooking medication causes: Always stop ACE inhibitors or sitagliptin if present 1
4. Underestimating opioid efficacy: While evidence quality is low, opioids remain the best-studied antitussives for refractory cough 4
5. Premature imaging: Chest X-ray has low yield (~5%) in nontraumatic chest wall pain without red flags 3